The following industry supported product theaters have been scheduled in conjunction with the Midyear Clinical Meeting. For more information, contact the company and/or individual listed.
Click here, to access Product Theater guidelines and application information.
Sunday, December 04, 2011 | |
| |
9:00 AM - 10:00 AM
|
| Revisiting Hypoglycemia, Supported by Novo Nordisk. Contact Mark Bell, Synapse Medical Communications; 646-416-5156 |
| Hilton Riverside Grand Salon A, Slot 1 |
| |
9:00 AM - 11:00 AM
|
| Recognition and Treatment of HypoNatremia in the Hospital Setting , Supported by Otsuka America Pharmaceutical, Inc. . Contact Dawn DeWitt, Phoenix Marketing Solutions; 908-222-4860 |
| Hilton Riverside Grand Salon B, Slot 2 |
| |
10:00 AM - 12:00 PM
|
| How to Implement a Multidose Medication Dispensing for Discharge Service: Tips and Tools , Supported by sanofi-aventis US. Contact Erika Thomas, ASHP Advantage; 301-664-8653 |
| Hilton Riverside Grand Ballroom A, Slot 11 |
| |
12:00 PM - 2:00 PM
|
| New Directions in the Management of Postsurgical Pain , Supported by Pacira Pharmaceuticals. Contact Alexis Beckel, Pacira Pharmaceuticals; 973-254-3575 |
| Hilton Riverside Grand Salon A, Slot 3 |
| |
12:00 PM - 2:00 PM
|
| The Role of BRILINTA™ (ticagrelor) Tablets in the Management of ACS Patients, Supported by AstraZeneca . Contact Sherri Lynn Poston, AstraZeneca; 785-312-9922 |
| Hilton Riverside Grand Salon B, Slot 4 |
| |
Tuesday, December 06, 2011 | |
| |
12:00 PM - 2:00 PM
|
| A Focus on Vaccinating Adults in the Hospital: New Quality Measures and Best Practices, Supported by Pfizer. Contact Scott Duncan, Hudson Global; 914-332-1515 x1130 |
| Exhibit Hall, Slot 7 |
| |
Wednesday, December 07, 2011 | |
| |
11:30 AM - 1:30 PM
|
| TEFLARO (ceftaroline fosamil) – A Clinical Data Review, Supported by Forest Pharmaceuticals, Inc.. Contact Forest Pharmaceuticals |
| Exhibit Hall, Slot 9 |
| |